BAM 13 (6), 2003
Table of Contents
Molecular
Therapy for Muscular Dystrophy
Ryoichi
Matsuda, Guest Editor
Editorial
275
International
Symposium
on "Molecular Therapy for Muscular Dystrophy
"Tokyo,
Japan,
November 26-27,
2002", Forewords
Teruo Shmizu
Review
277
The role of satellite
cells and circulating
stem cells in regeneration of skeletal muscle
T
Partridge [Full text
pdf 116 Kb]
Articles
281
Treatment
of Duchenne
Muscular Dystrophy with oligonucleotides against an
exonic splicing
enhancer
sequence
M
Matsuo, M Yagi and Y Takeshima
[Full
text pdf 412 Kb]
287
Fukuyama-type
congenital
Muscular Dystrophy and abnormal glycosylation of a
dystroglycan
T Toda,
K Kobayashi, S Takeda,
J Sasaki, H Kurahashi, H Kano, M Tachikawa, F Wang,
Y
Nagai, K Taniguchi, M Taniguchi,
Y Sunada, T Terashima, T Endo and K Matsumura
[Full
text pdf 817 Kb]
293
Direct evidence
that EXP/muscleblind interacts with CCUG tetranucleotide
repeats
Y Kino,
Y Oma, Y Takeshita,
D Mori, N Sasagawa and S Ishiura
[Full
text pdf 365 Kb]
299
Matrix
metalloproteinase
activity that disrupt the dystroglycan complex: its role
in the
molecular
pathogenesis
of
muscular dystrophies
K Matsumura, K Arai, D Zhong,
F Saito, H Fukuta-Ohi, R Maekawa, H Yamada and T
Shimizu [Full text pdf
514 Kb]
305
Decreased
expression of alpha-B-crystallin in C2C12 cells that
express human
DMPK/160CTG
repeats
Y
Takeshita, N Sasagawa, F
Usuki and S Ishiura
[Full text pdf
165 Kb]
309
Analysis
of telomere length in the aged mdx diaphragm with and
without
transgenic
IGF-I expression
ER
Barton and HL Sweeney
[Full text
pdf 302 Kb]
313 Negamycin-therapy
in skeletal and cardiac muscles of mdx mice
M
Arakawa, M Shiozuka, Y Nakayama,
T Hara, M Hamada, D Ikeda, Y Takahashi, R Sawa, Y Nonomura,
K
Sheykholeslami,
K Kondo, K Kaga,
S Takeda,
and R Matsuda [Full
text pdf 729
Kb]
Perspectives
321 Duchenne
Muscular
Dystrophy: It is time to in vivo test TEST
(Targeted-Exon-Skipping
Therapy)
U
Carraro [Full text pdf
126 Kb]
Myology
News &
Events 325
2004 Myology Conferences